Cetrimide is an antiseptic which is a mixture of different quaternary ammonium salts including cetrimonium bromide (CTAB).[1] It was first discovered and developed by ICI and introduced under the brand name Cetavlon.[2] It is used as a 1-3 % solution for cleaning roadside accident wounds.[3] Another antiseptic chlorhexidine was also discovered and first developed by ICI. ICI also introduced Savlon which was a combination of cetrimide and chlorhexidine. ICI later sold the Savlon brand OTC to Johnson & Johnson in May 1992.[4]


  1. Ito., Emma (November 2009). "Editorial". Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer. 76 (5): 969–983. Retrieved November 2009. Check date values in: |accessdate= (help)
  2. http://newspapers.nl.sg/Digitised/Article/straitstimes19721231.2.68.1.aspx
  3. Tripathi, KD. Essentials of Medical Pharmacology (7th ed.). p. 900.
  4. http://www.thefreelibrary.com/JOHNSON+%26+JOHNSON+ACQUIRES+SAVLON+OTC+BRANDS+FROM+ICI-a012169404
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.